LivaNova (LIVN) Return on Sales (2014 - 2026)

LivaNova (LIVN) posted Return on Sales of 0.0% for Q1 2026, down 25.41% sequentially from 0.0% in Q4 2025, and up 1.0% YoY from 0.0% in Q1 2025.

LivaNova (LIVN) Return on Sales (2014 - 2026) Analysis & Trends

LivaNova has reported Return on Sales for 13 years, with the latest figure at 0.0% in Q1 2026.

Quarterly Return on Sales rose 1.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
Return on Sales retreated to 0.0% in Q1 2026 per LIVN's latest filing, from 0.0% in the prior quarter.
Over five years, Return on Sales peaked at 0.0% in Q4 2024 and troughed at 0.01% in Q1 2025.
A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Sales.
The sharpest annual moves came in 2025 and 2026: Return on Sales decreased 1 bps in 2025, then rose 1 bps in 2026.
Over 5 years, Return on Sales stood at 0.0% in 2022, then surged by 758 bps to 0.0% in 2023, then jumped by 229 bps to 0.0% in 2024, then slumped by 51 bps to 0.0% in 2025, then retreated by 25 bps to 0.0% in 2026.
According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Abbott Laboratories	198.93 Bn	193.33 Bn	7.27 Bn	0.00%
2	Stryker	127.82 Bn	124.35 Bn	4.50 Bn	0.00%
3	Medtronic	118.80 Bn	109.58 Bn	6.41 Bn	0.00%
4	Boston Scientific	73.38 Bn	72.84 Bn	3.85 Bn	0.00%
5	Edwards Lifesciences	51.95 Bn	47.70 Bn	1.35 Bn	0.00%
6	Dexcom	34.44 Bn	32.50 Bn	830.00 Mn	0.00%
7	GE HealthCare Technologies	33.91 Bn	31.80 Bn	2.18 Bn	0.00%
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn	0.00%
9	Steris	23.10 Bn	22.62 Bn	684.20 Mn	0.00%
10	LivaNova	4.29 Bn	3.77 Bn	273.67 Mn	0.00%

Download Data